Geneticist Dr. Karen Lee argues that personalized medicine based on genetic profiles will become standard care within a decade. She points to rapid advances in gene sequencing technology and increasing evidence of genetic influences on drug responses.
Which development would best support Lee's timeline prediction?
The cost of full genome sequencing dropped from 200 in 2023, and 50 major hospitals now adjust 30+ drug dosages based on patients' genetic profiles
Genetics research receives significant funding
Some diseases have genetic components
DNA was discovered decades ago
Correct Answer: A
Choice A is the best answer. Cost drop + widespread hospital adoption shows the trajectory toward standard care.
- Context clues: Lee claims personalized medicine will be "standard" within a decade.
- Evidence evaluation: 200 cost drop + 50 hospitals already using it = rapid adoption path.
- Verify: Both the technology enabler (cheap sequencing) and adoption (30+ drugs) are shown.
💡 Strategy: Timeline predictions need evidence of acceleration in both technology and adoption.